These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2917113)

  • 1. Adrenal cortical reserve in patients undergoing muscle biopsy for malignant hyperthermia screening.
    Fairbrass MJ; Coe P; Ellis FR
    Br J Anaesth; 1989 Jan; 62(1):66-9. PubMed ID: 2917113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and muscle biopsy findings in malignant hyperthermia susceptibility.
    Ranklev E; Henriksson KG; Fletcher R; Germundsson K; Oldfors A; Kalimo H
    Acta Neurol Scand; 1986 Dec; 74(6):452-9. PubMed ID: 3825502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological support for the difference between malignant hyperthermia susceptible (MHS), equivocal (MHE) and negative (MHN) muscle biopsies.
    Mezin P; Payen JF; Bosson JL; Brambilla E; Stieglitz P
    Br J Anaesth; 1997 Sep; 79(3):327-31. PubMed ID: 9389850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia.
    Ording H; Hedengran AM; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Nov; 35(8):711-6. PubMed ID: 1763590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vecuronium and doxapram in patients susceptible to malignant hyperthermia.
    Ording H; Fonsmark L
    Br J Anaesth; 1988 Mar; 60(4):445-9. PubMed ID: 2895665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of malignant hyperthermia reactions in 2,214 patients undergoing muscle biopsy.
    Carr AS; Lerman J; Cunliffe M; McLeod ME; Britt BA
    Can J Anaesth; 1995 Apr; 42(4):281-6. PubMed ID: 7788824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propofol is a 'safe' anaesthetic agent in malignant hyperthermia susceptible patients.
    McKenzie AJ; Couchman KG; Pollock N
    Anaesth Intensive Care; 1992 May; 20(2):165-8. PubMed ID: 1595850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-in-1 lumbar plexus block for muscle biopsy in malignant hyperthermia patients. Amide local anaesthetics may be used safely.
    Gielen M; Viering W
    Acta Anaesthesiol Scand; 1986 Oct; 30(7):581-3. PubMed ID: 3811802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cocaine on the contracture response to 1% halothane in patients undergoing diagnostic muscle biopsy for malignant hyperthermia.
    Sato N; Brum JM; Mitsumoto H; DeBoer GE
    Can J Anaesth; 1995 Feb; 42(2):158-62. PubMed ID: 7720160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium and its antagonism by neostigmine (plus glycopyrrolate) in patients susceptible to malignant hyperthermia.
    Ording H; Nielsen VG
    Br J Anaesth; 1986 Sep; 58(9):1001-4. PubMed ID: 3092848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects.
    Kelestimur F; Akgün A; Günay O
    J Endocrinol Invest; 1995 Dec; 18(11):823-6. PubMed ID: 8778152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of malignant hyperthermia susceptibility. 2. Anesthesia for muscle biopsy. Differential diagnosis in negative test results].
    Breucking E; Mortier W
    Anaesthesist; 1993 Oct; 42(10):684-90. PubMed ID: 8250202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sixty-minute post-Synacthen serum cortisol level: a reliable and cost-effective screening test for excluding adrenal insufficiency compared to the conventional short Synacthen test.
    Mansoor S; Islam N; Siddiqui I; Jabbar A
    Singapore Med J; 2007 Jun; 48(6):519-23. PubMed ID: 17538749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle relaxation rates in individuals susceptible to malignant hyperthermia.
    Urwyler A; Ellis FR; Halsall PJ; Hopkins PM
    Br J Anaesth; 1990 Sep; 65(3):421-3. PubMed ID: 2223371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility. The European Malignant Hyperpyrexia Group.
    Br J Anaesth; 1984 Nov; 56(11):1267-9. PubMed ID: 6487446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An image analysis study of vastus lateralis muscle fibers in malignant hyperthermia susceptible patients.
    Zukowski F; De Craemer D; Van den Branden C; De Cauwer H; Heytens L; Martin JJ
    Clin Neuropathol; 1998; 17(1):6-11. PubMed ID: 9496533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis of susceptibility to malignant hyperthermia in children].
    Krivosic-Horber R; Adnet P; Krivosic I; Reyford H
    Arch Fr Pediatr; 1990; 47(6):421-4. PubMed ID: 2403268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of malignant hyperthermia in Denmark and Sweden.
    Ording H; Ranklev E; Fletcher R
    Br J Anaesth; 1984 Nov; 56(11):1183-90. PubMed ID: 6487440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of otolaryngic patients susceptible to malignant hyperthermia without dantrolene.
    Derkay CS; Grundfast KM
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):680-6. PubMed ID: 1754251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.